Position in BMY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$770,551
-$46,585 QoQ
Shares Held
13,373
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,306
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlas Brown,Inc. holds $23,716,828 across 9 Drug Manufacturers - General names. BMY ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,094 | $8,150,913 | |
| 2 | ABBV |
AbbVie Inc.
|
30,004 | $7,550,205 | |
| 3 | LLY |
ELI LILLY & Co
|
2,009 | $2,409,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,181 | $2,079,258 | |
| 5 | PFE |
Pfizer Inc
|
80,876 | $1,947,493 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
13,373 | $770,551 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,508 | $443,200 | |
| 8 | GSK |
GSK plc
|
4,053 | $212,458 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $770,551 | 13,373 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $817,136 | 13,473 | Shares | Defined | 2026-04-17 | |
| 2025-12-31 | $726,786 | 13,474 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $728,951 | 16,163 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $748,879 | 16,178 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $990,355 | 16,238 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $936,577 | 16,559 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $829,961 | 16,041 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $740,230 | 17,824 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $965,022 | 17,795 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $926,863 | 18,064 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,062,712 | 18,310 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $1,302,341 | 20,365 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,406,299 | 20,290 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,446,626 | 20,106 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $1,448,743 | 20,379 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $1,565,564 | 20,332 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,470,166 | 20,131 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,273,561 | 20,426 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,144,525 | 19,343 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,292,365 | 19,341 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $1,070,053 | 16,950 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $1,025,852 | 16,538 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,014,982 | 16,835 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $989,780 | 16,833 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $948,471 | 17,016 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||